据《卫报》基于英国国家卫生服务(NHS)商业服务局数据的调查显示,英格兰地区有数百名未成年人正在接受GLP-1类减肥药物的处方治疗 1。在2025至2026财年期间,共有419张此类处方开给18岁以下儿童,其中10张针对的是12岁以下的儿童 1。若仅统计今年4月至7月的数据,则有341张GLP-1处方发放给了儿童患者,在这批处方中,有15名患者的年龄不足12岁 1。需要指出的是,上述统计数据来源于NHS商业服务局,并未涵盖私立医疗体系、监狱系统以及医院内部配药的处方记录,因此实际使用GLP-1类减肥药物的儿童数量可能高于现有公开数据 1。
这一现象与世界卫生组织(WHO)上月发布的最新全球指南存在明显差异,该指南建议肥胖药物不应给予10岁以下儿童 1。尽管面临低龄使用的争议,制药巨头诺和诺德公司开展的一项涉及165名6至12岁以下儿童的临床试验显示,GLP-1类药物对年轻肥胖儿童具有潜在疗效 1。背景数据显示,儿童肥胖问题在英国日益严峻,根据英国国家儿童测量计划的结果,10至11岁儿童的肥胖率已达到22.8% 1。对此,专家强调,鉴于当前严峻的儿童肥胖危机,这些药物需在专业医疗监控下谨慎使用 1。
Investigative data reveals that hundreds of children in England are being prescribed GLP-1 weight-loss medications. 1 For the 2025–26 fiscal year alone, there were 419 prescriptions for these drugs issued to patients under the age of 18, with 10 specifically targeting children younger than 12 years old. 1 Records from April to July of this year show 341 GLP-1 prescriptions for children, including 15 patients who had not yet reached their 12th birthday. 1
These figures originate from the NHS Business Services Authority and do not include private prescriptions, medication dispensed within prisons, or doses prepared internally at hospitals, suggesting that the actual number of children receiving these treatments may be higher than reported. 1 This trend persists despite recent global health recommendations; just last month, the World Health Organization released updated global guidelines advising that obesity medications should not be administered to children under the age of 10. 1
The prescription data coincides with growing concerns over childhood obesity in the region. 1 According to the National Child Measurement Programme, 22.8% of children aged 10 to 11 in England are classified as obese. 1 Medical trials conducted by Novo Nordisk involving 165 children aged 6 to under 12 have indicated that GLP-1 drugs can be beneficial for young patients struggling with obesity. 1 Experts emphasize that while these medications may offer effective treatment options, their use requires strict professional medical monitoring to address the escalating crisis safely. 1
评论
还没有评论,欢迎留下第一条。